Michaelidou Maria, Yadegarfar Ghasem, Morris Lauren, Dolan Samantha, Robinson Adam, Naseem Asma, Livingston Mark, Duff Chris J, Trainer Peter, Fryer Anthony A, Heald Adrian H
Department of Endocrinology and Diabetes, Salford Royal Hospital, Salford.
The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester, UK.
Cardiovasc Endocrinol Metab. 2021 Apr 12;10(2):137-145. doi: 10.1097/XCE.0000000000000250. eCollection 2021 Jun.
The short synacthen test (SST) is the most commonly performed investigation to assess adrenal function. Appropriate criteria for when an SST is performed are subject to debate. We investigated how random serum cortisol levels relate to SST response.
We examined random cortisol measurements taken between 04.40-23.55 p.m. results of SST baseline and 30-/60-min cortisol performed over 12 months (225 SSTs) at Salford Royal Hospital. Serum cortisol was measured on the Siemens Centaur Analyser.A 30-60-min cortisol concentration of ≥450 nmol/L defined a pass; 350-449 nmol/L defined borderline.
Patients only proceeded to SST if random cortisol was <400 nmol/L. For those not on corticosteroids for at least 2 weeks, 42/43 (97.7%) cases with random cortisol concentration of ≥200 nmol/L had an SST 'pass'. The relation was less clear with corticosteroid treatment (19/35 cases; 54%).For those not taking glucocorticoid treatment (including inhaled/topical corticosteroids) in the previous 2 weeks, 91.8% of SSTs were pass/2.7% borderline/5.5% fail. For those on steroids, 51.9% of SSTs were a pass/11.4% were borderline.In relation to the postsynacthen cortisol pass cut-off of ≥450 nmol/L, in 15/207 (7.2%) of cases, the 60-min cortisol was ≥450 nmol/L (adequate adrenocortical function), but 30-min cortisol was below this. In all cases where the 30-min cortisol did indicate a pass (i.e. was ≥450 nmol/L) the 60-min cortisol was also ≥450 nmol/L.
Our findings suggest that if the random cortisol level is ≥200 nmol/L, regardless of the time of day and the person was not taking corticosteroid treatment in the previous 2 weeks, SST may not be needed. Our data also suggests that 60-min cortisol retains utility.
短促肾上腺皮质激素试验(SST)是评估肾上腺功能最常用的检查。进行SST的合适标准存在争议。我们研究了随机血清皮质醇水平与SST反应之间的关系。
我们检查了索尔福德皇家医院在12个月内(225次SST)于下午4点40分至晚上11点55分之间采集的随机皮质醇测量值、SST基线结果以及30/60分钟时的皮质醇水平。血清皮质醇在西门子Centaur分析仪上进行测量。30 - 60分钟时皮质醇浓度≥450 nmol/L定义为通过;350 - 449 nmol/L定义为临界值。
仅当随机皮质醇<400 nmol/L时患者才进行SST。对于那些至少2周未使用皮质类固醇的患者,43例中有42例(97.7%)随机皮质醇浓度≥200 nmol/L的患者SST“通过”。在使用皮质类固醇治疗的患者中这种关系不太明确(35例中有19例;54%)。对于那些在过去2周内未接受糖皮质激素治疗(包括吸入/局部皮质类固醇)的患者,91.8%的SST通过/2.7%为临界值/5.5%未通过。对于使用类固醇的患者,51.9%的SST通过/11.4%为临界值。关于促肾上腺皮质激素刺激后皮质醇通过临界值≥450 nmol/L,在207例中有15例(7.2%),60分钟时皮质醇≥450 nmol/L(肾上腺皮质功能正常),但30分钟时皮质醇低于此值。在所有30分钟时皮质醇确实显示通过(即≥450 nmol/L)的病例中,60分钟时皮质醇也≥450 nmol/L。
我们的研究结果表明,如果随机皮质醇水平≥200 nmol/L,无论一天中的时间如何,且该人在过去2周内未接受皮质类固醇治疗,则可能不需要进行SST。我们的数据还表明60分钟时的皮质醇仍有作用。